Full name
MGM PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
46.76.Z - Wholesale of other intermediate products
46.46.Z - Wholesale of pharmaceutical goods
46.75.Z - Wholesale of chemical products
49.41.Z - Freight transport by road
52.10.B - Warehousing and storage of other goods
52.24.C - Cargo handling in other reloading points
68.10.Z - Buying and selling of own real estate
68.20.Z - Rental and operating of own or leased real estate
73.20.Z - Market research and public opinion polling
77.39.Z - Rental and leasing of other machinery, equipment and tangible goods not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 4,6 | 6,3 | 6,5 | 4,1 |
EBITDA | 5,4 | 7,2 | 5,9 | -18 |
Short time liabilities | 9,3 | 8,5 | 5,4 | -36,6 |
Equity capital | 3,9 | 4,5 | 1,9 | -56,7 |
Operating profit (EBIT) | 5,4 | 7,2 | 5,9 | -18,3 |
Assets | 13,2 | 13 | 7,4 | -43,1 |
Net profit (loss) | 4,6 | 6,3 | 6,5 | 4,1 |
Cash | 0,9 | 0,6 | 1,1 | 86,3 |
Net income from sale | 34,2 | 40,7 | 33,5 | -17,6 |
Liabilities and provisions for liabilities | 9,3 | 8,6 | 5,5 | -36 |
Working assets | 13,2 | 13 | 7,3 | -43,9 |
Depreciation | 0 | 0 | 0 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 117,7 | 140,2 | 336,9 | 196,7 |
Equity capital to total assets | 29,5 | 34,3 | 26,1 | -8,2 |
Gross profit margin | 13,4 | 15,4 | 19,5 | 4,1 |
EBITDA Margin | 15,7 | 17,7 | 17,7 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 99 | 77 | 59 | -18 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane